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Abstract 
This paper reports on the findings from the application of a recently reported 
approach to modelling health state valuation data.  The approach applies a 
nonparametric model to estimate the revised version of the Health Utilities Index 
Mark 2 (HUI 2) health state valuation algorithm using Bayesian methods.   The data 
set is the UK HUI 2 valuation study where a sample of 51 states defined by the HUI 2 
was valued by a sample of the UK general population using standard gamble.  The 
paper presents the results from applying the nonparametric model and compares these 
to the original model estimated using a conventional parametric random effects 
model. The two models are compared in terms of their predictive performance.  The 
paper discusses the implications of these results for future applications of the HUI 2 
and further work in this field. 
 
 
JEL classification: I1  
 
Key words: Preference-based health measure; HUI 2; nonparametric methods  
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 1. Introduction  
 
There has been an increasing use of preference-based measures of health related 
quality of life in order to calculate quality adjusted life years for use in cost 
effectiveness analyses. These preference-based measures are standardised multi-
dimensional health state classifications with pre-existing preference or utility weights 
elicited from a sample of the general population.  There are currently a number of 
such preference-based measures, including the EQ-5D (Brooks, 1996), HUI2 & 3 
(Torrance et al, 1996; Feeny et al, 2002), 15D (Sintonen, 1994, 1995), AQoL 
(Hawthorn et al, 2001), QWB (Kaplan et al, 1988) and the SF-6D (Brazier et al, 
2002).  All of these measures describe a large number of health states, such that it is 
not feasible to obtain direct valuations for each health state. Thus models are 
constructed to predict the values for all states in a descriptive system based upon 
direct valuations of a sample of states. 
 
Health state values present a significant challenge for conventional statistical 
modelling procedures due to their nature, namely: skewed, truncated, non-continuous 
and hierarchical (Brazier et al, 2002).  Attempts to statistically model these data have 
met with some success in the EQ-5D, SF-6D and HUI2 (Dolan, 1997 and Brazier et 
al, 2002, McCabe et al 2005a). However, there were concerns with the size of the 
prediction errors, non-monotonicity in some estimated health state values and an 
apparent systematic pattern in the prediction errors. Recently, Kharroubi et al (2005) 
reported an alternative, non-parametric Bayesian method for modelling health state 
preference data. This paper reports the application of this method to the UK HUI2 
valuation data reported by McCabe et al, and compares the results with the 
conventional random effect regression model.  
 
 
The next section of this paper provides a brief description of the UK HUI2 valuation 
survey. A detailed description has been reported elsewhere. (McCabe et al, 2005a)     
In section 3 the results from each approach are presented and compared in terms of 
their ability to predict actual values. We conclude with a discussion of the results and 
their implication for the HUI2 and future approaches to modelling health state 
preference data. 
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2. The Health Utilities Index Mark 2 
 
The HUI2 is a preference-based multi-attribute health related quality of life 
instrument specifically developed for use with children.(Torrance et al, 1996) It 
consists of seven attributes (sensation, mobility, emotion, cognition, self care, pain 
and fertility), each of which has between three and five levels. The levels describe a 
range, from ‘normal functioning for age’ to ‘extreme disability’. (Table 1). When it is 
used as a generic instrument, fertility is excluded. (Torrance et al, 1996). The generic 
version of the instrument was used for the UK valuation survey. 
 
As part of a large study of outcomes following paediatric intensive care in the United 
Kingdom, 3 separate valuation surveys were undertaken. These have been described 
in detail elsewhere. (McCabe 2005a, b). The work reported in this paper utilises the 
data from two of those surveys. 
 
One hundred and ninety nine respondents provided valuations for 51 health states in 
the HUI2 descriptive system, using the standard gamble technique following the 
methods described by Furlong et al. (1990)  The mean number of valuations per 
health state was 24 (range 9 to 29).   
 
Fifty one respondents provided valuations for 14 health states from the HUI2 
descriptive system not valued in the Valuation Survey, using the same standard 
gamble technique and script as in the Valuation Survey. 
 
3. Modelling 
The generic HUI2 descriptive system describes 8000 possible health states and the 
empirical survey could obtain valuations for only a small subset. The aim of 
modelling is to estimate health state utility values for all states.  The utility associated 
with a health state is assumed to be a function of that state, hence by estimating a 
relationship between the descriptive system and the observed values we can infer 
values for all states. Valuation surveys generate data with a complex structure 
creating a number of problems for estimation and a variety of techniques have been 
used to deal with these problems.  In the main these have used parametric 
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relationships with particular assumptions about functional form, but here we contrast 
this conventional parametric approach reported by McCabe et al (2005a) with a more 
realistic and flexible nonparametric model.  
A general model for health state valuations can be described by: 
 ijjijij fy ea += ),(x ,   (1)  
where, for i = 1, 2, …, jn  and  j = 1,2, …, m, xij is the i
th health state valued by 
respondent j and the dependent variable yij is the adjusted SG score given by 
respondent j for that health state. The general model has two sets of independent, 
zero-mean, random effect terms: ije  is a random error term associated with each 
observation and ja  is a term to allow for individual characteristics of respondent j.   
The interpretation of ),( jijf ax  is as the true indifference SG value that respondent j 
has for health state ijx . The objective is to obtain a health state utility measure for the 
population as a whole, and this is generally taken to be the mean of the respondent-
level health state utilities across the population.  In order to account for different 
populations, it is possible to model ja  in terms of respondent-level covariates such as 
age, gender or socio-economic factors, but the principal objective of the HUI2 
valuation study was to estimate a health state utility function for the UK population as 
a whole.   
 
3.1 The parametric approach  
McCabe et al (2005a) specify the following model for respondent j’s health state 
utility: 
jijjijf ama +¢+= )(),( xIx θ ,   (2) 
where m  and θ  denote unknown parameters, )( ijxI  is a vector of dummy explanatory 
variables. In the simplest, no-interactions, case of this model, )( ijxI  is a vector of 
terms )( ijI xdl  for each level l > 1 of dimension d of the HUI 2.  For example, 
)(32 ijI x  denotes dimension d = 3 (emotion), level l = 2 (Occasionally fretful, angry, 
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irritable, anxious depressed or suffering from “night terrors”).  For any given health 
state ijx , )( ijI xdl  is defined as: 
)( ijI xdl  = 1 if, for state ijx , dimension d is at level l. 
)( ijI xdl  = 0 if, for state ijx , dimension d is not at level l 
In all, there are 21 of these terms, with level l = 1 acting as a baseline for each 
dimension. Hence the intercept parameter m  represents the health state utility value 
for state (111111), and summing the coefficients dlq  of the ‘on’ dummies derives the 
value of any other state.  
More generally, )( ijxI  can include additional dummy variables to account for 
interactions between the levels of different dimensions, and the model selected by 
McCabe et al (2005a) included no such interaction term.  
Estimation of this random effects model is via generalised least squares or maximum 
likelihood.   Since ja  has zero mean, the population health state utility for state x in 
this model is simply )(xIθ ¢+m . 
 
3.2 The nonparametric approach  
Kharroubi et al. (2005) build a new Bayesian statistical nonparametric model to 
describe the intrinsic characteristics of individual health state valuation data that is 
argued to be more theoretically appropriate than previous parametric models. For 
respondent j, the health state utility of state ijx  is 
 { })(1)exp(1),( ijjjij uf xx --= aa  .  (3)  
Note that the individual respondent term ja  enters multiplicatively rather than 
additively as in (2).  In the Kharroubi et al. (2005) model, the distribution of ja  is  
aj ~ ),( 2' tqjtN  
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where jt  is the vector of covariates for respondent j. Note here that t’s are centred to 
ensure that they have zero means, and hence that the value of )exp(a  for a typical 
person is 1. 
The term u(x) is the median health state utility of health state x.1 It is treated as an 
unknown function and in a nonparametric framework it therefore becomes a random 
variable.  The model for u(x) is 
u(x) ~ ),(N 2sg xβ¢+ ,    (4) 
and furthermore the values of )(xu  and )(x¢u  for two different states x and x¢  have a 
correlation ),( xx ¢c  which decreases as the distance between x and x¢  increases.  The 
effect of this is to assert that if x and x¢  describe very similar health states (in the 
sense that their levels are the same or close in all dimensions) their utilities will be 
approximately the same, and so the preference function varies smoothly as the health 
state changes.   
Note that the mean health state utility in (3) is  
 { })(11)( xx uu --= a  , 
where a  is the mean value of )exp(a  over the whole population.  This will not in 
general be 1, and so the population (mean) health state utility is not the same as the 
median health state utility u(x).  More details of the nonparametric modelling and 
evaluation of a  are given in Kharroubi et al (2005). 
The models and the programs to undertake the Bayesian approach were written in 
Matlab and are available on our website (http://www.shef.ac.uk/chebs). 
 
4. Results  
Given the overall aim is to predict health states valuations, the best way to compare 
the two models is via their predictive ability. The models are compared on Figures 1 
and 2, where the predicted and actual mean values for the 51 health states valued in 
                                                
1 Consider the case when there are no covariates, the distribution of ja  is normal, so it has zero 
median as well as zero mean, and the median of )exp( ja  is therefore 1. 
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the survey have been plotted with health states ordered by actual health state values.  
Figure 1 presents the resulting predicted mean health state valuations (dotted line) for 
the parametric model (2), along with actual mean health state valuations (solid line). 
The dashed line represents the errors obtained by the difference between the two 
valuations. Figure 2 presents the corresponding plots for the nonparametric model.  
There is a very close level of agreement between the parametric and non-parametric 
model. The only exception to this being state (3,1,3,3,3,1). The parametric model 
predicts the observed mean value considerably more accurately than the non-
parametric model. We consider this finding in more details below. 
 
Table 2 shows the inference for the mean health state utility values of the 51 health 
states valued in the Valuation Survey and the 12 states that were valued in the 
Validation Survey.  For each state, Table 2 reports the observed sample mean health 
state utility and the predicted mean and standard deviation for the population mean 
health state utility from both the nonparametric and parametric models. The states 
marked with an asterisk were not valued in the valuation survey.  Across the 51 states 
that were used in the study, the predictive performance of the nonparametric model is 
better than the parametric model overall, with a root mean square error (RMSE) of 
0.055 for the nonparametric model and 0.060 for the parametric model.  Very few 
health states are valued worse than death in either model. Finally, it can be seen that 
the standard deviations of the predictions are larger for the parametric model.  
 
As always, it is important to check the validity of the assumed models. Figure 3 plots 
a histogram of residuals across all 1370 health state valuations for the parametric 
model and Figure 4 plots the corresponding residuals for the nonparametric model. 
According to these models we would expect these to be approximately normal. 
Figures 3 and 4 broadly support this, although there is some evidence of skewness 
which is more obvious in Figure 3. This is not surprising, given the negative skewness 
in the original SG data at the individual level. However, the degree of skewness is 
probably not high enough to invalidate the analyses in both models, which assume 
normally distributed errors.  An important finding of Figures 3 and 4 is that the 
nonparametric model clearly yields smaller residuals, and so fits the data better.  The 
RMSE at the individual level is 0.2267 for the nonparametric model and 0.3403 for 
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the parametric model.  However, this in part reflects fact that the histogram for the 
parametric model has been calculated the frequentist way, regarding the individual 
random effects as being just random and so part of the error.  The histogram for the 
nonparametric model has been calculated using the Bayesian convention, in which the 
random effects are handled more like a fixed effect in frequentist terms.   
A better test of the validity of the model is to investigate its ability to predict the 
values for states that have not been used in the estimation. Data relating to 10 selected 
health states were removed from the estimation data, and the models fitted on data for 
the remaining 41 states. Table 3 presents the true sample means for the 10 omitted 
states, together with their predicted mean and standard deviation values from the 
parametric and nonparametric models estimated on the reduced data set.  The 
predictive performance of the nonparametric model is better than the parametric 
model overall, with RMSEs of 0.050 and 0.090 respectively.  It can be seen that the 
nonparametric model predicts the omitted data quite well, and better than the 
parametric model. It is to be noted that the predictive standard deviations here for 
both models are larger than those in Table 2, because the model in Table 2 is 
predicting the data on which it was estimated, whereas the model in Table 3 is 
predicting out of sample data. The parametric standard errors are larger than the 
nonparametric ones, primarily because the nonparametric analysis is able to make use 
of other evaluations by the same respondents to estimate their individual random 
effects, which the frequentist analysis can not do.  
 
Figures 5 and 6 show the Q-Q plots of standardised predictive errors for the 12 health 
states sample means, for the parametric and nonparametric models respectively. In 
each figure the straight line corresponds to the theoretical N(0,1) distribution. Figure 5 
suggests that the parametric model is not well validated by its predictive performance. 
In contrast, it is apparent from Figure 6 that the nonparametric model predictions are 
well validated. The mean of the standardised residuals for the parametric model is      
-0.66 compared to -0.14 for the nonparametric one.  
 
To capture the impact of the respondent characteristics, Figure 7 shows the 
histograms of the conditional posterior distribution functions of the covariates sex and 
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age. These results indicate that age has a strong effect, as it is not centred on zero.  
Sex is centred very close to zero, and thus has a negligible effect. To demonstrate the 
impact of adjusting for age on the mean health state values, results are presented for 
the states listed in Table 2 with and without adjusting for covariates. Actual UK age 
distribution was taken from the UK census of 2001 (www.statistics.gov.uk/census).  
These results show that the largest differences between health state values are for the 
most severe HUI 2 health state.  Mean health state values for the pits state are            -
0.0256 and -0.0018 with and without adjusting for age respectively with difference of 
0.0238. This difference declines as states become milder.  This suggests that the 
magnitude of the gain of moving from a severe to mild state will be a smaller for 
older age groups. We consider this finding in more detail in the discussion section. 
 
5. Discussion 
 
This paper reports the findings from applying a new approach to modelling health 
state valuation data.  The approach applies a nonparametric model to estimate health 
state utility values for the HUI2 using Bayesian methods.  We have presented two sets 
of analyses; the first has compared a Bayesian main-effects model with the existing 
conventional main effects model, (McCabe 2005a). The second has utilised the 
flexibility of the non-parametric Bayesian method to examine the impact of covariates 
on health state values.  
 
The main effects Bayesian model represents a significant improvement on the 
conventional model. Perhaps more importantly, the Bayesian method is more robust 
to reductions in the quantity of data available for model estimation, than the 
conventional model. The conventional model estimated on 41 health states produces a 
number of large prediction errors.  This is perhaps unsurprising, as the Bayesian 
method supplements the data with prior knowledge on the correlation between health 
state values.  It is important that the specified co-relations are acceptable to the users 
of the modelled values.  Assuming this criterion is met, the Bayesian modelling 
approach makes efficient use of the information provided by typically small health 
state valuation surveys. 
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It is worth noting that the Bayesian model produces a very poor prediction for one 
state (313331). The explanation for this may lie in considering the nature of this 
health state. It combines substantial limitations in sensation, emotion, cognition, and 
self-care with full functioning on mobility and freedom from pain.  This health state 
may well have been extremely difficult for respondents to visualise. Is it plausible that 
an individual can combine ‘Able to walk, bend, lift, jump and run normally for age’ 
with  ‘Requires mechanical equipment to eat, bathe, dress, or use the toilet 
independently’? The potential problem with the plausibility of the health state is 
confounded by the small number of observations for the health state; n=9.  There were 
relatively few observations for one other health state, (122222), however both models 
produce reasonable predictions for this state, suggesting that the plausibility of state 
(313331) is the more likely explanation of the poor predictive performance. To 
facilitate comparison with the published statistical model we have reported the model 
estimated on the 51 states. (McCabe 2005a).   However, Figures 8 and 9 report the 
results of the Bayesian main effects model estimates on the dataset with state 
(313331) and both states (313331) and (122222) excluded respectively. It is clearly 
that the Bayesian model is improved as a result of this exclusion.  
 
As reported earlier, the covariates analysis showed that whilst gender is not an 
important determinant of health state values, whilst age is. For milder health states, 
the predicted values do not vary much with age; however, the more severe the health 
state, the greater the impact of age on the health state value.   There are at least two 
possible explanations for this result. Older respondents may genuinely put a lower 
value on lower levels of functioning; i.e the more time you have lived, the more 
important it is that the remaining years are lived at a reasonable level of functional 
health. Alternatively, it may be that younger respondents did not adhere to the 
instruction that the health state would last for 60 years or assumed that over such a 
long period of time, advances in medical science would improve the level of health 
related quality of life associated with any given functional condition. It may also be 
that the cognitive burden of the HUI2 question was too great and the values obtained 
were artefacts of the process and do not reflect actual preferences. 
 
This result is, to some degree, at odds with the existing literature on the relationship 
between age and health state values. Normally, it is argued that as older people have 
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experience of ill-health, adaptation leads them to place higher values on poor health 
states compared to younger people. Analyses by Kharroubi et al of the SF-6D data has 
found this type of relationship.(Personal Communication). Dolan’s analysis of the UK 
EQ-5D data reported a similar relationship, however, the increasing value is only 
observed over a limited age range; by 50 years of age the EQ-5D data show the same 
decreasing value with age as seen in the HUI2 data. In addition, this relationship is 
more pronounced in the severe health states in both the HUI2 and EQ-5D datasets. 
 
These results do have important implications for the use of published valuation 
algorithms.  If the analyst is interested in obtaining an estimate of the current 
population mean value for a given health state, the effect of the changing age profile 
of the general population needs to be taken into account. 
(http://www.statistics.gov.uk/cci/nugget.asp?ID=949).  Our results indicate that, for 
any given health state, the current mean values should be lower than the values of 10 
years ago, because of the change in the age distribution of the population.  Thus, 
ceteris paribus the health gain from preventing individuals entering these health states 
will be greater and thus more cost effective.   
 
The observed relationship between age and utility may have implications for our 
understanding of the difference between patient and general population health state 
values. As ill-health is positively correlated with age; ceteris paribus, patients’ values 
are likely to be lower than general population values. Thus, the degree of adaptation 
that leads to the observation that patients value health states more highly than the 
general population may be larger than currently thought. At a minimum, future 
analyses of comparative data should control for age when estimating the scale of 
divergence between patient and general population values. 
 
The covariates model has the potential to estimate health state valuation tariffs for 
sub-groups of populations; and for populations with different socio-economic profiles.  
Such tariffs are valuable in their own right and would also be very useful in the design 
of HUI2 health state valuation surveys for other countries; acting as informative 
priors.  In addition, covariates models will allow the detailed exploration of the 
observed international variations in the health state value models for instruments such 
as the SF-6D, EQ-5D and HUI2. 
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Figure 1. Sample mean and predicted health states valuations for the parametric model.  
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Figure 2. Sample mean and predicted health states valuations for the nonparametric model. 
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Figure 3. Residuals for the parametric model for each of the 1370 individual health state 
valuations. 
 
Figure 4. Residuals for the nonparametric model for each of the 1370  individual health state 
valuation. 
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Figure 5.  Q-Q plot of standardised predictive errors for the parametric model for the 10 out 
of sample health states. 
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Figure 6.  Q-Q plot of standardised predictive errors for the nonparametric model for the 10 
out of sample health states. 
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Table 1: The Health Utilities Index Mark 2 
 
Dimension 
&Levels 
Description Dimension 
&Levels 
Description Dimension 
&Levels 
Description 
Sensation 
 Level 1 
Able to see, hear and speak 
normally for age 
Self Care 
 Level 1 
Eats, bathes, dresses and uses the 
toilet normally for age 
Emotion 
Level 1 
Generally happy and free from worry 
Level 2 Requires equipment to see or 
hear or speak 
Level 2 Eats, bathes, dresses or uses the 
toilet independently with difficulty 
Level 2 Occasionally fretful, angry, irritable, 
anxious depressed or suffering from “night 
terrors” 
Level 3 Sees, hears, or speaks with 
limitations even with 
equipment 
Level 3 Requires mechanical equipment to 
eat, bathe, dress, or use the toilet 
independently 
Level 3 Often fretful, angry, irritable, anxious 
depressed or suffering from “night terrors” 
Level 4 Blind, deaf, or mute Level 4 Requires the help of another 
person to eat, bathe, dress or use 
the toilet 
Level 4 Almost always fretful, angry, irritable, 
anxious, depressed 
    Level 5 Extremely fretful, angry, irritable, anxious 
or depressed usually requiring 
hospitalisation usually requiring 
hospitalisation or psychiatric institutional 
care 
Mobility    Level 1 Able to walk, bend, lift, jump 
and run normally for age 
Cognition    
Level 1 
Learns and remembers schoolwork 
normally for age 
  
Level 2 Walks, bends, lifts, jumps or 
runs with difficulty but does  
not require help 
Level 2 Learns and remembers schoolwork 
more slowly than classmates as 
judged by parents and/or teachers 
Pain      
Level 1 
Free of pain and discomfort 
Level 3 Requires mechanical 
equipment (such as canes, 
crutches, braces or a 
wheelchair) to walk or get 
around independently 
Level 3 Learns and remembers very slowly 
and usually requires special 
educational assistance 
Level 2 Occasional pain. Discomfort relieved by 
non-prescription drugs or self-control 
activity without disruption of normal 
activities 
Level 4 Requires the help of another 
person to walk or get around 
and requires mechanical 
equipment 
Level 4 Unable to learn and remember Level 3 Frequent pain. Discomfort relieved by oral 
medicines with occasional disruption of 
normal activities 
Level 5 Unable to control or use arms 
or legs 
  Level 4 Frequent pain. Frequent disruption of 
normal activities. Discomfort requires 
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prescription narcotics for relief 
    Level 5 Severe pain. Pain not relieved by drugs and 
constantly disrupts normal activities. 
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Table 2: Inference for the 63 health states 
Health 
 State N 
Observed 
Mean 
Non Parametric 
Posterior inference   
(No covariates) 
Parametric 
Posterior inference 
Non Parametric 
Posterior inference 
(Covariates)  
   Mean S.D. Mean S.D. Mean S.D. 
111232 29 0.6388 0.6616 0.0349 0.7201 0.0427 0.669 0.0339 
112123 26 0.7317 0.7068 0.0367 0.7381 0.0473 0.713 0.0362 
112222 21 0.7857 0.7174 0.0333 0.6880 0.0495 0.7234 0.0317 
121132 25 0.638 0.6533 0.0372 0.7241 0.0427 0.6611 0.0354 
122222 11 0.6227 0.6517 0.0339 0.6367 0.0553 0.6594 0.0331 
124134 26 0.4702 0.4353 0.0435 0.4918 0.0551 0.4499 0.0417 
125211 29 0.6103 0.59 0.0398 0.7096 0.0468 0.5985 0.0382 
125425 19 0.3395 0.2852 0.0528 0.2907 0.0650 0.3017 0.0498 
132332 23 0.4217 0.4927 0.0391 0.4625 0.0561 0.505 0.0383 
133213 22 0.6341 0.5676 0.04 0.5950 0.0576 0.5775 0.0406 
133444 28 0.3411 0.3274 0.0449 0.3204 0.0666 0.3444 0.0422 
141341 28 0.7089 0.6531 0.042 0.6558 0.0489 0.6622 0.0401 
142311 25 0.611 0.599 0.0412 0.6780 0.0449 0.6091 0.0403 
144325 22 0.2489 0.2655 0.048 0.2844 0.0642 0.2823 0.0461 
212314 28 0.508 0.5162 0.0394 0.5342 0.0514 0.5261 0.0375 
213321 23 0.4663 0.5356 0.0395 0.6263 0.0529 0.5459 0.038 
214242 25 0.41 0.4127 0.0424 0.4223 0.0613 0.4272 0.0409 
221214 21 0.6226 0.5801 0.0408 0.6181 0.0518 0.5883 0.0393 
221221 26 0.7683 0.7292 0.0348 0.7275 0.0499 0.7339 0.0336 
222142 28 0.5063 0.4814 0.0391 0.5133 0.0582 0.4933 0.0366 
222333 25 0.456 0.4266 0.0386 0.4142 0.0633 0.4411 0.0378 
223235 22 0.3807 0.3218 0.0435 0.2986 0.0670 0.3389 0.0427 
231412 21 0.5417 0.5008 0.0412 0.4858 0.0537 0.5113 0.0391 
234111 28 0.5723 0.5725 0.0365 0.5822 0.0485 0.5813 0.0359 
235121 22 0.5443 0.4863 0.0421 0.5280 0.0550 0.499 0.0408 
241423 23 0.3304 0.3681 0.0446 0.4196 0.0634 0.3822 0.043 
242135 26 0.2462 0.2908 0.0449 0.2911 0.0614 0.3082 0.0431 
255332 21 0.406 0.3176 0.0498 0.2689 0.0784 0.3353 0.0483 
311324 25 0.518 0.4725 0.0411 0.5681 0.0518 0.4848 0.0395 
313331 9 0.7028 0.4622 0.0411 0.5552 0.0524 0.4742 0.0399 
314431 22 0.3966 0.3646 0.0443 0.4141 0.0555 0.3807 0.0435 
315143 22 0.458 0.3596 0.0478 0.4613 0.0596 0.3771 0.0472 
315312 23 0.4315 0.4311 0.0439 0.4872 0.0525 0.4432 0.0431 
321345 28 0.408 0.3266 0.0456 0.3585 0.0619 0.3411 0.0437 
322221 29 0.6353 0.5927 0.0341 0.6244 0.0554 0.6009 0.0339 
322412 27 0.4611 0.4347 0.0399 0.4538 0.0574 0.448 0.0385 
323331 21 0.4976 0.4285 0.0394 0.5039 0.0579 0.4413 0.0378 
331131 23 0.5957 0.5967 0.0389 0.6407 0.0446 0.6056 0.0384 
331233 25 0.429 0.4164 0.04 0.4698 0.0599 0.43 0.0381 
332225 27 0.275 0.2947 0.0402 0.2986 0.0656 0.3106 0.0391 
342124 28 0.5205 0.4239 0.0413 0.4384 0.0596 0.4366 0.0395 
343112 27 0.5009 0.5021 0.0386 0.5240 0.0548 0.5135 0.037 
344222 20 0.3925 0.3525 0.0435 0.3471 0.0654 0.3663 0.0425 
412431 27 0.4389 0.4163 0.0422 0.3983 0.0560 0.4306 0.0409 
421114 25 0.481 0.4651 0.0441 0.5621 0.0499 0.4764 0.043 
 21 
423122 21 0.4429 0.4286 0.0447 0.4494 0.0620 0.4391 0.0424 
424313 23 0.3913 0.3507 0.045 0.3302 0.0645 0.3661 0.044 
431322 27 0.4287 0.404 0.0407 0.3940 0.0602 0.4177 0.0383 
445234 28 0.1857 0.1537 0.048 0.1285 0.0703 0.1718 0.0469 
452241 23 0.337 0.2928 0.049 0.3954 0.0771 0.311 0.0485 
455445 167 -0.0701 -0.0256 0.0363 -0.0609 0.0878 -0.0018 0.0327 
121434* NA NA 0.4654 0.0698 0.5056 0.0545 0.4784 0.0676 
211223* NA NA 0.6424 0.0473 0.6632 0.0537 0.6499 0.0459 
224112* NA NA 0.5742 0.0518 0.5430 0.0528 0.5824 0.0505 
232141* NA NA 0.5372 0.0541 0.5525 0.0543 0.5487 0.0522 
311124* NA NA 0.535 0.062 0.6643 0.0459 0.5449 0.0604 
322222* NA NA 0.5296 0.0405 0.5141 0.0605 0.5397 0.0398 
342223* NA NA 0.4015 0.0489 0.4287 0.0656 0.4151 0.0473 
341314* NA NA 0.3644 0.0677 0.4886 0.0536 0.3773 0.0655 
421313* NA NA 0.4363 0.0587 0.5116 0.0566 0.4487 0.0571 
444335* NA NA 0.0993 0.0632 -0.0034 0.0715 0.1187 0.0613 
221321* NA NA 0.6374 0.0469 0.6867 0.0496 0.6449 0.0455 
342411* NA NA 0.4305 0.0677 0.4839 0.0542 0.4433 0.0657 
* State valued in the validation survey 
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Table 3: Out of sample predictions for 10 health states 
 
 
 
Nonparametric 
posterior inference 
Parametric 
inference 
missing 
state 
 
 
 
N 
true 
sample 
mean Mean (s.d.) mean (s.d.) 
122222 11 0.6227 0.6462 0.0862 0.679 0.1120 
133213 22 0.6341 0.5655 0.0747 0.592 0.0874 
212314 28 0.5080 0.5157 0.0716 0.613 0.0782 
222142 28 0.5063 0.5434 0.0707 0.567 0.0829 
235121 22 0.5443 0.5294 0.0742 0.519 0.0865 
314431 22 0.3966 0.4247 0.0776 0.390 0.0858 
322221 29 0.6353 0.573 0.0629 0.664 0.0791 
332225 27 0.2750 0.3647 0.0706 0.354 0.0870 
421114 25 0.4810 0.4915 0.0843 0.649 0.0791 
452241 23 0.3370 0.4101 0.0873 0.481 0.0978 
 
Figure 7:  Conditional posterior distribution functions of the covariates Age and Sex. 
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Figure 8. Sample mean and predicted health states valuations for the nonparametric model 
excluding 313331 health state. 
Actual vs Predictive valuations
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Figure 9. Sample mean and predicted health states valuations for the nonparametric model 
excluding both 313331 and 122222 health states. 
Actual vs Predictive valuations
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